We’re reimagining diagnostics by

READING THE IMMUNE SYSTEM

Host Response Diagnostics

Delivering precision medicine on demand

SEE OUR PIPELINE

TedEx PaloAlto

The power of reading the immune system to better diagnose disease

Dr. Tim Sweeney, Inflammatix Co-Founder and CEO

Our tests are addressing significant clinical needs in acute infection and sepsis diagnosis that affect millions of people

host-response-diagram

In the News

Recent notable news stories

Artificial Intelligence for Clinical Decision Support in Sepsis

May 13, 2021

Inflammatix Checks off All the Right Boxes with Investors

March 19, 2021

Inflammatix nets $102M to advance its immune system tests for infectious diseases

March 16, 2021

A bright future ahead for novel markers of infection

December 15, 2020

Also covered by

SEE ALL NEWS

Stay in touch with social updates:
Find out the latest news.

Follow us on Twitter
Follow us on LinkedIn